94088-35-4

Usage

Uses

Used in Organic Synthesis:
(Z)-1-bromohept-3-ene is used as a reagent in the field of organic synthesis for the production of a diverse range of other organic compounds. Its unique structure, which includes a bromine atom and a carbon-carbon double bond, makes it a valuable building block in the creation of complex organic molecules.
Used in Pharmaceutical Production:
In the pharmaceutical industry, (Z)-1-bromohept-3-ene is employed as a key intermediate in the synthesis of various drugs. Its versatility in organic synthesis allows for the development of new pharmaceutical compounds with potential therapeutic applications.
Used in Agrochemical Production:
(Z)-1-bromohept-3-ene also finds application in the agrochemical sector, where it is used as a starting material for the synthesis of different agrochemicals. These may include pesticides, herbicides, and other chemicals that are essential for the protection and enhancement of crop yields.
Used in Fine Chemicals Production:
(Z)-1-bromohept-3-ene is also utilized in the production of fine chemicals, which are high-purity chemicals used in various industries, such as the fragrance, flavor, and specialty chemical markets. The unique properties of (Z)-1-bromohept-3-ene make it a valuable component in the synthesis of these high-quality chemicals.

InChI:InChI=1/C7H13Br/c1-2-3-4-5-6-7-8/h4-5H,2-3,6-7H2,1H3/b5-4+

Upstream product

• 105281-66-1 (3Z)-hept-3-en-1-yl methanesulfonate 
• 14916-79-1 3-heptyn-1-ol 
• 10606-47-0 hept-3-en-1-ol 
• 42976-91-0 3-chloro-2-propyl-tetrahydro-furan 
• 1708-81-2 (Z)-hept-3-en-1-ol 

Relevant academic research and scientific papers

A Heck-Based Strategy to Generate Anacardic Acids and Related Phenolic Lipids for Isoform-Specific Bioactivity Profiling

A synthetic strategy for phenolic lipids such as anacardic acid and ginkgolic acid derivatives using an efficient and selective redox-relay Heck reaction followed by a stereoselective olefination is reported. This approach controls both the alkene position and stereochemistry, allowing the synthesis of natural and unnatural unsaturated lipids as single isomers. By this strategy, the activities of different anacardic acid and ginkgolic acid derivatives have been examined in a matrix metalloproteinase inhibition assay.

Messenger RNA for the delivery composition and method (by machine translation)

The present invention provides compositions comprising the lipid particles of encapsulated in mRNA molecular composition. Said composite particle comprising a cationic lipid, a non-cationic lipid and encapsulated in the lipid particles of the mRNA molecules in the lipid particle. The composition (for example) is used for the introduction of human subject suffering from a mRNA molecule, they are subject in said translation in order to produce the used to improve one or more of the symptoms of the disease polypeptide. The invention also provides for the preparation of said composition of the present invention a cationic lipid. (by machine translation)

Regio-and enantioselective catalytic monoepoxidation of conjugated dienes: Synthesis of chiral allylic cis-epoxides

Ti(IV)-salan 4 catalyzes the diastereo-and enantioselective monoepoxidation of conjugated dienes using 30% H2O2 at rt or below even in the presence of other olefins and adjacent stereocenters. Its enantiomer, ent-4, provides access to the opposite diastereomer or enantiomer. The resultant chiral allylic epoxides, and the triols derived from them, are versatile synthetic intermediates as well as substructures present in many bioactive natural products. The epoxidation is highly specific for Z-olefins. For 1-acyl(silyl)oxypenta-2,4-dienes, epoxidation of the distal olefin is generally favored in contrast to the adjacent regioselectivity characteristic of Sharpless, peracid, and other directed epoxidations of hydroxylated dienes.

COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA

The present invention provides compositions comprising mRNA molecules encapsulated within lipid particles. The lipid particles comprise a cationic lipid, a non-cationic lipid, and an mRNA molecule that is encapsulated within the lipid particle. The compositions are useful, for example, to introduce the mRNA molecules into a human subject where they are translated to produce a polypeptide that functions to ameliorate one or more symptoms of a disease. The invention also provides cationic lipids that are useful for preparing the compositions of the invention.